Heart failure is a growing epidemic, especially in Taiwan because of the aging population.
The 2016 Taiwan Society of Cardiology–Heart Failure with reduced Ejection Fraction (TSOC …

Background: Most randomized trials on implantable cardioverter-defibrillator (ICD) use for
primary prevention of sudden cardiac death in heart failure with reduced ejection fraction …

Heart failure (HF) is the leading cause of morbidity and mortality worldwide and negatively
impacts quality of life, healthcare costs, and longevity. Although data on HF in the Arab …

Aims The objective of this paper is to assess whether cardiac contractility modulation (via the
Optimizer System) plus standard of care (SoC) is a costeffective treatment for people with …

Preliminary evidence suggests that poor patient-reported quality of life (QoL) predicts
mortality on the short term in patients with an implantable cardioverter defibrillator (ICD). It is …

Background Concerns about the efficacy of prophylactic ICD in non-ischemic
cardiomyopathy (NICM) heart failure (HF) patients are still present. We aimed to assess …

Objective: To determine the cost-utility relationship of an implantable cardioverterdefibrillator
compared to optimal pharmacological therapy for patients with ischemic or nonischemic …

Sudden cardiac death is a leading cause of death worldwide. That is the reason it requires
more focus on predicting the risk and identifying susceptible candidates to optimize risk and …

In dieser Arbeit sollten die Effekte einer Immunadsorptionstherapie (IA) und anschließender
intravenöser Immunglobulin (IVIG)-Gabe auf Patienten mit „recent-onset “dilatativer …

Sudden cardiac death (SCD) is a major disease burden often triggered by ventricular
arrhythmias in patients with underlying cardiac disease. Globally SCD has been estimated …